Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Palliative Care in ESRD

Every nephrologist has to eventually come to terms with the fact that, for ESRD patients, mortality is high with an annual 23% mortality in dialysis units. This overall high mortality...
CME credit is no longer available for this conference.

Course Authors

Frieda Wolf, M.D.

Dr. Wolf is Assistant Professor of Medicine, Department of Medicine, Downstate Medical Center, Brooklyn, New York.

Within the past 12 months, Dr.Wolf reports no commercial conflicts of interest.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Describe the increasing burden of comorbidities faced by geriatric patients with ESRD

  • Discuss the withdrawal/withholding of therapy and its consequences -- many symptoms and ultimately death for ESRD patients

  • Incorporate principles of end-of-life care into the care of the dialysis patient in order to improve their quality of life and quality of death.



This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.


Please click below to accept the terms of this CME activity

Courses You Might Like

Heat Stress, Climate Change, and Its Impact on Kidney Disease

The kidneys have a major role in maintaining a healthy extracellular environment within our bodies. Homeostasis is achieved by an elaborate intrarenal system that helps modulate extracellular and intracellular volume and electrolyte composition. Thus, the kidneys are great protectors for the host in the setting where alterations in temperature, humidity and access to water and/or food is limited. Just as the kidney is a major regulator of homeostasis, it has its own high energy demands and is especially susceptible to
Authors: Fumihiko Sasai, M.D., Ashio Yoshimura, M.D. and Richard J Johnson, M.D.
Estimated Time: 1 Hour

Home Dialysis -- The Future Is Now

This presentation may include discussion of commercial products and services. The prevalence of renal disease in the United States continues to increase dramatically. It is estimated that one in ten Americans have some level of chronic kidney disease (CKD). This represents more than 20 million patients in the United States with this ailment. The largest (and expanding) group of CKD patients are patients 65 years of age and older (see Figure 1). Only a minority of these
Authors: Annie-Claire Nadeau-Fredette, M.D., and Joanne M. Bargman, M.D.; Eduardo Alas, M.D., and Mark Unruh, M.D., M.S.
Estimated Time: 1 Hour

Diagnosis and Treatment of Kidney Cancer

Kidney cancer (also known as renal cell carcinoma or RCC) is diagnosed in 36,000 patients and is the cause of death of 11-13,000 individuals per year in the U.S. (See Figure 1). Several groups of patients are at high risk for this disease: African-Americans, obese individuals (whose numbers are markedly increasing in the U.S.) and smokers. In many cases, RCC is asymptomatic at presentation, and recent data from the NCI suggest that the increasing incidence of this disease is
Authors: Robert H. Weiss, M.D. and Hiromi Inoue, D.V.M.
Estimated Time: 1 Hour

Nephrogenic Systemic Fibrosis

Rarely do we have the chance to describe a new disorder or disease. Nephrogenic systemic fibrosis (NSF) presents such an opportunity. Once called nephrogenic fibrosing dermopathy, NSF is an acquired idiopathic disorder in patients with renal failure who develop fibrosis in skin and internal organs after exposure to gadolinium−containing contrast agents. NSF was first noted in 1997, and published in 2000 by Cowper in the Lancet. Fifteen cases of NSF were seen in 14 dialysis patients and one patient with
Authors: Frieda Wolf, M.D.
Estimated Time: 1 Hour

Nephrotic Syndrome

'bubbles appearing on the surface of the urine indicate renal disease and a prolonged illness discloses chronic inflammatory activity in the glomeruli and may be identified with the term chronic glomerulonephritis' Hippocrates, Aphorisms VII, 34(6) The GBM is composed of three layers: the fenestrated endothelial cells lining the inside of the glomerular capillary; the glomerular basement membrane (GBM) and the podocyte; and foot processes with their intervening slit diaphragm. The slit diaphragm constitutes a porous filter structure of nephrin
Authors: Frieda Wolf, M.D.
Estimated Time: 1 Hour

Renal Transplantation: Immunity and Viral Infections

An antigen presenting cell (APC) begins by phagocytizing the foreign particle. It is then 'chopped up' and binds to MHC II proteins on the cell membrane. This begins the cascade of T cell activation. MHC class II proteins activate T helper cells by binding CD4 proteins on their surface. These helper cells further activate proliferation of subtypes of T cells some of which are other T helper cells, but others are cytotoxic T cells or memory T cells.
Authors: Frieda Wolf, M.D.
Estimated Time: 1 Hour